Table 2 Previous treatments
Characteristic | No | % |
|---|---|---|
No. of previous treatment lines | ||
2 | 9 | 19.2 |
3 | 19 | 40.4 |
4 | 19 | 40.4 |
Regorafenib before TAS-102 | ||
Yes | 28 | 59.6 |
No | 19 | 40.4 |
Response to first-line chemotherapy | ||
CR | 1 | 2.1 |
PR | 15 | 31.9 |
SD | 22 | 46.8 |
PD | 9 | 19.2 |
Characteristic | No | % |
|---|---|---|
No. of previous treatment lines | ||
2 | 9 | 19.2 |
3 | 19 | 40.4 |
4 | 19 | 40.4 |
Regorafenib before TAS-102 | ||
Yes | 28 | 59.6 |
No | 19 | 40.4 |
Response to first-line chemotherapy | ||
CR | 1 | 2.1 |
PR | 15 | 31.9 |
SD | 22 | 46.8 |
PD | 9 | 19.2 |